Cloudbreak Pharma, Inc.
Irvine, United States (US) · Health and Medical
Do you work at Cloudbreak Pharma, Inc.?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Cloudbreak Pharma, Inc. is a Health and Medical company based in Irvine, United States (US), founded in 2015, with 50-100 employees. Cloudbreak Pharma, Inc.'s profile is verified on Enterprise League.
Overview
Cloudbreak Pharma is an innovative ophthalmic drug company and leader in ocular R&D, based in Irvine, California.
We are dedicated to developing first-in-class and best-in-class ophthalmic drugs, leveraging our proprietary Multi-Kinase Inhibitors (MKI) platform. Our lead asset, the eye drop CBT-001, is currently in mid-Phase 3 clinical trials for pterygium, a condition affecting millions globally. CBT-004 is also progressing into Phase 3 for pinguecula, offering the potential for the first and only FDA-approved therapies for these significant unmet needs.
Cloudbreak Pharma’s team comprises experienced ophthalmologic scientists and business professionals, committed to bringing innovative treatments from pre-clinical development to NDA approval. We’ve established strategic partnerships with Santen Pharmaceutical and Grand Pharma to expand our reach and commercialization efforts across key regions, including Japan, China, Hong Kong, Taiwan, and Southeast Asia. Our mission is to ‘Seeing Life Better, Through Medicine.’
We are dedicated to developing first-in-class and best-in-class ophthalmic drugs, leveraging our proprietary Multi-Kinase Inhibitors (MKI) platform. Our lead asset, the eye drop CBT-001, is currently in mid-Phase 3 clinical trials for pterygium, a condition affecting millions globally. CBT-004 is also progressing into Phase 3 for pinguecula, offering the potential for the first and only FDA-approved therapies for these significant unmet needs.
Cloudbreak Pharma’s team comprises experienced ophthalmologic scientists and business professionals, committed to bringing innovative treatments from pre-clinical development to NDA approval. We’ve established strategic partnerships with Santen Pharmaceutical and Grand Pharma to expand our reach and commercialization efforts across key regions, including Japan, China, Hong Kong, Taiwan, and Southeast Asia. Our mission is to ‘Seeing Life Better, Through Medicine.’
Contact Details
info@cloudbreakpharma.com
Irvine, United States (US), 8921 Research Dr
+3
Founded
2015
Company Type
Public Limited Company
Employees
50-100
Categories
Keywords
#drug development with a focus on creating innovative treatment for ocular diseases
Companies teams usually look at after Cloudbreak Pharma, Inc.
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.